Advancell Partners With Lilly on Alpha Therapies for Cancer
February 11, 2025
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly